RNA sequencing first converts cellular RNA into complementary DNA, or cDNA, which can be sequenced as a more tractable molecular representation. Computational analysis then aligns the resulting sequences to a reference genome or transcriptome. This alignment provides the basis for identifying which transcripts are present and quantifying their representation, linking sequence data to gene activity measurements.
The reference genome or transcriptome provides the framework for computational alignment. It allows measured sequence fragments to be associated with particular transcripts and supports transcript identification and quantification. This step converts raw sequencing results into organized measurements that can be compared across samples or cells, making the data biologically interpretable.
Comparisons across samples link expression differences to biological conditions such as disease, development, or an experimental treatment. By examining which transcripts change in abundance between groups, researchers can identify condition-associated patterns and generate hypotheses about regulation. The resulting contrasts are useful for studying responses rather than viewing each sample as an isolated measurement.
Single-cell measurements preserve information about individual cells rather than representing only a combined cellular population. This resolution helps researchers distinguish cell types and developmental states and examine how those populations vary within a tissue or condition. It is especially useful when biologically important changes may be associated with particular cells instead of the sample as a whole.
A typical RNA-sequencing workflow begins with cellular RNA, converts it to complementary DNA, sequences that material, and computationally aligns the sequences to a reference genome or transcriptome. The analysis then identifies and quantifies transcripts. Researchers can apply the resulting measurements to individual cells or compare them across samples, depending on the experimental design.
Within biology, transcriptomics data support cell-type characterization, developmental studies, disease-associated comparisons, and analyses of responses to environmental or experimental treatments. They can also contribute to biomarker discovery and systems-level investigations of biological regulation. In practice, these uses make the data valuable for describing coordinated changes in gene activity and formulating testable research hypotheses.